Compare · head to head
Certara vs Metagenomi Therapeutics
Certara ranks higher overall — 360 rank 45 vs 24.
Certara leads on Value (58 vs 39) and Safety (58 vs 32). Metagenomi Therapeutics leads on Growth (50 vs 26). The two are close on Quality and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Technology | Biotechnology |
| Size | Medium | Small |
| ISIN | US15687V1098 | US59102M1045 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 45 | 24 |
| Value | 58 | 39 |
| Quality | 51 | 52 |
| Growth | 26 | 50 |
| Safety | 58 | 32 |
| Sentiment | 52 | 49 |
| Quality details | ||
| Profitability | 32 | 52 |
| Cash Truth | 70 | 52 |
Certara vs SchrödingerCertara vs InotivCertara vs Aurinia PharmaceuticalsCertara vs MedpacesAdd a third stock →
Full analyses: Certara · Metagenomi Therapeutics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100